Atlas Trials

CTC Changes and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer

Clinical trial NCT04059003 · UNKNOWN

Trial details

NCT number
NCT04059003
Sponsor
Shengjing Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast Neoplasms
Start date
2019-11-01
Primary completion
2023-08-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.